Table 3.

Methylation and OS and DFS in patients with endometrioid endometrial cancer

OS
DFS
HR (95% CI)PHR (95% CI)P
MLH11.290 (0.847-1.964)0.2361.315 (0.879-1.967)0.182
SESN30.997 (0.598-1.663)0.9920.912 (0.555-1.498)0.716
TITF10.927 (0.613-1.404)0.7220.892 (0.600-1.327)0.574
TITF1 + MLH11.072 (0.812-1.416)0.6221.072 (0.812-1.416)0.622
TITF1 + SESN30.957 (0.703-1.303)0.7790.957 (0.703-1.303)0.779
SESN3 + MLH11.124 (0.841-1.503)0.4301.124 (0.841-1.503)0.430
MLH1 + SESN3 + TITF11.045 (0.836-1.306)0.7011.045 (0.836-1.306)0.700